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Background and aims: The cellular and molecular events involved in ischaemia reperfusion (IR) injury are
complex and not fully understood. Previous studies have implicated polymorphonuclear neutrophils (PMN)
as major inflammatory cells in IR injury. However, anti-PMN antiserum treatment offers only limited
protection, indicating that other inflammatory cells are involved. We have therefore investigated the
contribution of resident macrophages in IR injury using an IR gut injury model.
Methods: DA rats were divided into sham operation and IR groups. The superior mesenteric artery was
clamped for 30, 45, or 60 minutes (ischaemia) followed by 60 minutes of reperfusion. IR injuries were
evaluated by histological staining. Expression of early growth response factor 1 (Egr-1), myeloperoxidase
(MPO), and proinflammatory cytokines was analysed by immunohistochemistry, reverse transcription-
polymerase chain reaction, and western blotting analysis. The specific role of macrophages in IR gut injury
was also evaluated in resident macrophage depleted rats.
Results: Mucosal sloughing and villi destruction were seen in 45/60 minute and 60/60 minute IR guts.
PMN infiltration at the damaged mucosal area was undetectable in 45/60 minute and 60/60 minute IR
guts. PMN were localised around the capillaries at the base of the crypts in 60/60 minute IR gut. Obvious
PMN infiltration was only observed in damaged villi after three hours of reperfusion. Elevated nuclear
Egr-1 immunostaining was localised in resident macrophages at the damaged villi before histological
appearance of mucosal damage. Furthermore, resident macrophages at the damaged site expressed
MPO. Protein levels of the proinflammatory cytokines RANTES and MCP-1 were increased in IR gut.
Depletion of resident macrophages by dichloromethylene bisphosphonate significantly reduced mucosal
damage in rat guts after IR.
Conclusion: Our findings indicate that resident macrophages play a role in early mucosal damage in IR
gut injury. Therefore, macrophages should be treated as a prime target for therapeutic intervention for IR
damage.
T
he intestinal mucosa, which lines the lumen of the
intestine, acts as a defence barrier against pathogen
invasion. Ischaemia reperfusion (IR) causes damage to
the intestinal mucosa, producing increased gut permeability
and bacterial translocation which can result in systemic
inflammatory response syndrome and multiple organ failure.
IR injury associated mortality remains high despite advances
in patient care for IR injury.1 The cellular and molecular
events involved in IR injury are complex, involving the
production of reactive oxygen species (ROS), reactive nitro-
gen species, and polymorphonuclear neutrophils (PMN)
infiltration. This is accompanied by the release of other
moderators such as nitric oxide, platelet activation factor, and
phospholipase A2.2 Recruitment of PMN into reperfused sites
after ischaemia is critical for IR injury in the heart, lung, and
liver.3–5 Anti-PMN antiserum treatment offers only limited
protection against IR injury in the heart.6 This suggests that
other inflammatory cells are likely to be involved. For
example, mast cells have also been suggested to play a role
in IR injury,7 and anti-complement agent K-76COONa, which
prevents mast cell degranulation, has been shown to
ameliorate gut IR injury. However, K-76COONa also inhibits
other inflammatory cells such as macrophages8 and lympho-
cytes.9 Identifying the additional inflammatory cells that
contribute to gut IR injury remains a priority for the
development of an effective treatment strategy directed
towards specific cellular targets.
Macrophages are inflammatory cells, which on activation
by bacterial lipopolysaccharide destroy bacteria by the release
of cytokines, ROS, induction of myeloperoxidase (MPO)
activity, and phagocytosis of bacteria.10 Acute inflammation
induces PMN infiltration and increases MPO activity in situ,
causing local tissue damage.11 Elevated MPO activity occurs
in an IR injured gut and localises to the ischaemic site shortly
after reperfusion and before the appearance of tissue
damage.12 Activated macrophages exhibit high levels of
MPO activity.13 14 Activation of macrophages mediates the
apoptosis of stromal, parenchymal, and other immune cells.15
Chloramines, which are catalytic products of MPO, can cause
growth arrest and apoptosis in gastric mucosal cells.16 17
However, it is still unclear whether the increased MPO
activity at the IR site is produced as a result of infiltrated
PMN, activated macrophages in situ, or both.18 Mucosa
damage is an early histological landmark of IR injury to the
gut2 19 which manifests functionally as increased gut perme-
ability. Macrophages mainly locate at the mucosa and
smooth muscle layers of the intestine, and are termed either
mucosal or muscularis resident macrophages. Hierholzer et al
have shown that muscularis resident macrophages release
Abbreviations: IR, ischaemia reperfusion; PMN, polymorphonuclear
neutrophils; Egr-1, early growth response factor 1; MPO,
myeloperoxidase, RT-PCR, reverse transcription-polymerase chain
reaction; ROS, reactive oxygen species; ICAM-1, intercellular adhesion
molecule 1; MCP-1, monocyte chemoattractant protein 1; SMA, superior
mesenteric artery; Cl2MBP, dichloromethylene bisphosphonate; PBS,
phosphate buffered saline; iNOS, inducible nitric oxide synthase; LFA-1,
lymphocyte function associated antigen 1
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the proinflammatory cytokine interleukin 6 and directly
contribute to decreased gut motility in the IR injured gut.20
However, the role of mucosal resident macrophages in
intestinal IR injury has not been investigated.
Early growth response factor 1 gene (Egr-1) encodes a
transcription factor and controls the development of the
central and peripheral nervous systems.21 In vitro studies
have identified downstream target genes of Egr-1. These
include genes encoding tumour necrosis factor a, intercellular
adhesion molecule 1 (ICAM-1), CD44, platelet derived
growth factor A/B chain, transforming growth factor b, and
macrophage colony stimulating factor.22 Expression levels of
Egr-1 are upregulated in the heart,23 24 lung,22 and kidney25 26
after IR challenge. These findings indicate that Egr-1 is
involved in IR injury in these organs. The involvement of Egr-
1 in IR injury is substantiated by findings that lung injury is
less severe and associated with improved survival after IR in
Egr-1 knockout mice.22 Production of the proinflammatory
cytokine monocyte chemoattractant protein 1 (MCP-1) and
adhesion molecule ICAM-1 in IR injured lungs is lower in
Egr-1 knockout mice. This probably accounts for the reduced
PMN infiltration and mild lung damage seen in lung IR
injury in Egr-1 knockout mice.
We hypothesise that resident macrophages play a key role
in the initiation of intestinal IR injury. To test our hypothesis,
we investigated the cellular and molecular events involved in
early gut mucosal damage from IR. We showed in a rat IR gut
injury model: (i) the onset of mucosal damage before PMN
infiltration; (ii) activation of mucosa resident macrophages
in the IR injured gut; (iii) expression of high levels of MPO
and Egr-1 in activated resident macrophages; and (iv)
depletion of intestinal resident macrophages, which pre-
vented IR injury to the gut in rats.
MATERIALS AND METHODS
Rat IR gut model
Six to eight week old DA rats (,250 g) were divided into
sham operation and IR groups. Rats were anaesthetised by
intraperitoneal injection (45 mg/kg body weight) of pento-
barbital sodium solution (Abbott Lab, Illinois, USA). The
superior mesenteric artery (SMA) was occluded by clamping
for 30 (n=6), 45 (n=6), or 60 minutes (n=6). A change in
colour of the occluded intestine from red to pale immediately
after clamping indicated successful induction of ischaemia.
After induction of ischaemia, clamps were released and guts
were reperfused for 60 minutes. In the sham operation
groups, SMA was separated but no occlusion was applied for
30+60 minutes (n=6), 45+60 minutes (n=6), or
60+60 minutes (n=6). The operation site was covered with
cotton gauze soaked with saline. Segments of the jejunum
(8–10 cm) of the IR and sham operation rats were collected
for RNA, protein, and immunohistochemistry. The study was
approved by the ethics committee of the University of Hong
Kong.
Macrophages depletion
Liposome encapsulated dichloromethylene bisphosphonate
(Cl2MBP liposome) or phosphate buffered saline (PBS,
control liposome)27 was provided by Roche Diagnostics
(Mannheim, Germany) and encapsulated in liposomes in
Dr Rooijen’s laboratory. The Cl2MBP or control liposome
(4 ml) was injected into the intraperitoneal cavity three days
before IR. The liver and jejunum were removed and depletion
of macrophages in these organs was verified by immuno-
staining for resident macrophage. Rats were injected with
Cl2MBP liposome (n=4) or control liposome (n=4), and
subjected to 45 minutes of ischaemia and 60 minutes of
reperfusion.
Immunohistochemistry and immunofluorescence
staining
Gut specimens were fixed in 4% paraformaldehyde/PBS
(pH 7.2) at 4 C˚ for 18 hours, dehydrated in alcohol, cleared
in xylene, and embedded in paraffin. Sections (4 mm
thickness) of jejunum were mounted onto TESPA
(3-aminopropyl-triethoxy-silane; Sigma, St Louis, Missouri,
USA) coated microscope glass. Antigen unmasking was
performed by heating the sections in 10 mM of citrate buffer
(pH 6.2) for 10 minutes at 95 C˚. Sections were incubated in
3% (v/v) H2O2 in methanol to quench endogenous peroxidase
activity. Tissue sections were blocked with Dako protein block
(Dako A/S, Glostrup, Denmark) and incubated with Egr-1
(Santa Cruz Biotechnology, California, USA; 1:800), ED1
(Serotec; 1:100), ED2 (Serotec, Kidlington, Oxford, UK;
1:200) ICAM-1 (Santa Cruz Biotechnology; 1:100), or rat
PMN (Accurate, New York, USA; 1:10 000) antibodies in
50 mM Tris buffer (pH 7.4) containing 1% bovine serum
albumin (USB Corporation, Ohio, USA) at 37 C˚ for 40 min-
utes or 4 C˚ for 16 hours. ED1 antibody recognises a
cytoplasmic antigen in monocytes and infiltrating macro-
phages, and is used as a pan macrophage marker.28 ED2
antibody, which recognises a membrane bound antigen
similar to human CD163, has been commonly used as a
specific maker for resident macrophages.28 29 Signal amplifi-
cation and detection were performed with the Dako EnVision
System, HRP. Sections were counterstained with haematox-
ylin, dehydrated in ethanol, cleared in xylene, and mounted
with DPX mounting medium (BDH Laboratory Supplies,
Poole, Dorset, UK). Immunofluorescence staining was
performed by incubating FITC and TRITC conjugated
secondary antibodies on sections and mounting them in
DAPI containing Vectashield mounting medium (Vector
Laboratories, California, USA). Immunofluorescent stained
sections were analysed with a fluorescence microscope
(Nikon Eclipse E600). Three jejunum sections of each rat in
different treatment groups were analysed for histology and
immunohistochemistry. Rats of the same group showed
similar histology and immunostaining pattern.
Representative pictures of haematoxylin/eosin or immuno-
stained sections of each group were shown for comparison.
Quantitative analysis of macrophages and PMN in gut
Numbers of ED2 and ED1 immunopositive cells were counted
from 10 randomly selected high power (4006) fields of
jejunum sections. The ratio of ED2 to ED1 immunopositive
cells was tabulated under different treatments. Egr-1
immunopositive cells were counted and separated into two
groups: cells showing cytoplasmic Egr-1 staining and cells
showing nuclear Egr-1 staining. A minimum of three sections
of each rat was examined and 10 randomly selected high
power (4006) fields of each gut section were examined. Two
observers counted the sections separately, and the results
were averaged and tabulated.
Table 1 Primers used for the polymerase chain reactions
Primer Sequence
Egr-1: sense 59-CCG GTT GCC TCC CAT CAC CTA-39
Egr-1: antisense 59-GAG CGA AGG CTG CTG GGT ACG-39
MPO: sense 59 CCG CAG GAC AAG TAT CGA A 39
MPO: antisense 59 ATC TGG TTG CGA ATG GTA ATG 39
b-actin: sense 59-TGG AAT CCT GTG GCA TCC ATG AAA C-39
b-actin: antisense 59-ACC ATC AAG GCA CAG CAA CTC-39
Egr-1, early growth response factor 1; MPO, myeloperoxidase.
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Quantitative analysis of PMN in gut
Numbers of PMN (immunopositive for anti-PMN antibody)
were counted from 10 randomly selected high power (4006)
fields of jejunum sections, and three sections of each rat were
examined. Two observers counted the sections separately,
and the results were averaged and tabulated.
Quantitative analysis of mucosal damage
Sloughing of villi tips2 was used as a histological criterion of
IR induced mucosal damage in Cl2MBP or control liposome
treated rats. Five randomly selected low power (1006) fields
of gut mucosa sections were examined, and the numbers of
damaged villi and the total number of villi were recorded.
Three sections from each rat were examined. Two observers
counted the sections separately, and the results were
averaged and tabulated.
Reverse transcription-polymerase chain reaction
(RT-PCR)
Expression of Egr-1 and b-actin was analysed by RT-PCR. Full
thickness gut wall was used for total RNA isolation using
Trizol (Invitrogen, Carlsbad, California, USA). First strand
cDNA was synthesised from 1 mg of total RNA using oligo
d(T)12–18 as a reverse primer and SuperScript First-strand
synthesis System (Invitrogen). PCR was performed in 25 ml
of standard buffer containing primers (1 mM each; table 1),
cDNA (3 ml), 0.25 units of AmpliTaq Gold (Applied
Biosystems, California, USA), MgCl2 (1.5 mM), and dNTP
(0.2 mM each). After initial denaturation (94 C˚, three
minutes), PCR was performed for 30 cycles for Egr-1, MPO,
and b-actin as follows: 30 seconds at 94 C˚; one minute at
60 C˚; and one minute at 72 C˚ for each cycle. A final extension
for 10 minutes at 72 C˚ was added. PCR products were
analysed by electrophoresis in 1% agarose gel. Intensities of
PCR bands were quantified and relative expression levels of
Egr-1 to b-actin were determined using Scion Image software
(Scion Co, Massachusetts, USA).
Western blotting analysis
Total proteins, and cytoplasmic and nuclear protein fractions
were prepared as previously described.30 Equal amounts of
protein (50 mg or 20 mg in the case of nuclear protein) of each
sample were separated in 12.5% sodium dodecyl sulphate
polyacrylamide gels before being electrotransferred onto a
PVDF membrane (Amersham Bioscience, Hong Kong, China)
in a transfer buffer (48 mM Tris, 39 mM glycine, 20%
methanol, pH 9.2). The membrane was blocked in PBST
(pH 7.2, 0.1% Tween 20) containing 10% (w/v) skimmed
milk for one hour before incubation with primary antibodies
in PBST against Egr-1 (Geneka Biotechnology, Quebec,
Figure 1 Ischaemia reperfusion (IP)
injury of gut occurs before
polymorphonuclear neutrophil (PMN)
infiltration. Sections of jejunum of
different IR groups were stained with
haematoxylin and eosin. Clear mucosal
damage was observed in the 45/
60 minute (459/609) IR gut (B) but not
in the 30/60 minute (309/609) IR gut
(A). Sections of sham controls and IR
groups were immunostained with anti-
PMN antibody (C–E). Few PMN
(arrows) were localised in the 45/
60 minute IR jejunum (C). PMNs were
detected near and inside the blood
capillaries at the base of the crypt of the
60/60 minute IR jejunum (D; inset).
Heavy PMN infiltration was detected in
the 45/180 minute IR jejunum (E).
1774 Chen, Lui, Rooijen, et al
www.gutjnl.com
 on 29 January 2007 gut.bmj.comDownloaded from 
Canada; diluted 1:1000), RANTES, ICAM-1, MCP-1 (Santa
Cruz Biotechnology; diluted 1:100), or actin (Santa Cruz
Biotechnology; diluted 1:2000) for 16 hours at 4 C˚. After
three PBST washings, blots were incubated with appropriate
horseradish peroxidase conjugated secondary antibodies
(Zymed, California, USA) in PBST for one hour at ambient
temperature. After three PBST washings, signal detection was
performed with an ECL kit (Amersham Bioscience).
Statistical analysis
Means (SEM) of the relative expression of Egr-1 to b-actin,
ratio of ED2 to ED1 immunopositive cells, and ratio of
damaged villi to total villi were determined for each group.
One way (and non-parametric) ANOVA, with Newman-
Keuls multiple comparison test was used (GraphPAD
Software, San Diego, California, USA) to evaluate the
significance of the differences between different treatments,
and a p value ,0.05 was considered significant.
RESULTS
Localisation of PMN in the gut after IR injury
To define a time point for early intestinal damage after IR,
histological analyses were performed on IR guts treated with
different periods of ischaemia (10, 30, 45, 60, and 120 min-
utes) and reperfusion (1, 3, 6, and 15 hours). Histological
analyses showed that reperfusion after SMA clamping caused
IR induced gut damage characterised by mucosal damage,
sloughing of the mucosal epithelium, and villi destruction
observed in the IR jejunum at 45/60 minutes (fig 1B).
Mucosal damage was not evident in the jejunum of either
the 30/60 minute IR group (fig 1A) or the sham operation
group (data not shown). To localise the infiltrated PMN in
the IR jejunum, immunohistochemistry using antirat PMN
antibody was performed. Only a few PMN were detected in
the damaged villi of the jejunum of the 45/60 minute (0.7
(0.16):0.65 (0.23); IR:sham) and 60/60 minute IR groups
(1.25 (0.28):0.8 (0.2); IR:sham) (fig 1C, D). In the
60/60 minute IR gut, PMN were localised near and inside
the blood capillaries at the base of the crypt (fig 1D). In
contrast, extensive PMN infiltration was detected in
damaged villi after prolonged reperfusion (three hours)
(28.35 (2.65):0.5 (0.15); IR:sham; p,0.001) (fig 1E).
MPO expression and localisation
Absence of infiltrated PMN in damaged villi of the
45/60 minute IR jejunum prompted us to investigate the role
of resident macrophages in mucosal damage. We performed
immunofluorescent staining on sections of 45/60 minute IR
jejunum using anti-MPO and ED2 antibodies (fig 2A).
Expression of MPO overlapped with that of ED2. ED2
immunopositive resident macrophages also stained for
inducible nitric oxide synthase (iNOS) and lymphocyte
function associated antigen 1 (LFA-1) (fig 2B; data not
shown). Expression levels of MPO in the IR jejunum and the
Figure 2 Resident macrophages express myeloperoxidase (MPO) and inducible nitric oxide synthase (iNOS) in ischaemia reperfusion (IR) gut.
Sections of 45/60 minute (459/609) IR jejunum were immunostained using anti-MPO and ED2 antibodies (A). ED2 immunoreactive resident
macrophages were also immunoreactive for MPO. Adjacent sections were immunostained with anti-iNOS antibody and ED-2 antibody (B). ED2
immunopositive were also iNOS positive. Protein extracts of the sham operation and IR jejunum of 30/60 minute (309/609) and 45/60 minute (459/
609) ischaemic groups were analysed by western blotting (C). Levels of MPO were increased in the 30 minute and 45 minute IR jejunum (IR) but a
negligible level of MPO was detected in the sham operation jejunum (sham). MPO mRNA levels were similar between the sham operation and IR
jejunum, as revealed by reverse transcription-polymerase chain reaction (D).
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sham operation jejunum were analysed using western
blotting. Levels of MPO were increased markedly in the 30/
60 minute and 45/60 minute IR jejunum while the amount of
MPO in the sham operation jejunum was negligible (fig 2C).
Similar intensities of actin were observed in all lanes,
indicating that equivalent amounts of protein extracts of
each sample were analysed. RT-PCR analysis revealed similar
levels of MPO mRNA in both sham controls and IR groups
(fig 2D) suggesting that MPO induction in our IR model was
regulated at the translation level.
Expression of mRNA and protein of Egr-1 gene in IR
gut
To investigate if upregulation of Egr-1 of resident macro-
phages is crucial for gut IR injury, a kinetic study of Egr-1
expression in the IR jejunum was performed. Relative
expression levels of Egr-1 mRNA to b-actin mRNA were
determined in IR jejunum, sham operation jejunum, and
control jejunum. The relative expression level of Egr-1 mRNA
increased by 3.9-fold in the 30/60 minute IR jejunum
compared with sham operation jejunum (Egr-1/b-actin 1.8
(0.19):0.46 (0.29); IR:sham; p,0.01) and by threefold in the
45/60 minute IR jejunum compared with the sham jejunum
(Egr-1/b-actin 0.75 (0.23):0.25 (0.05); IR:sham; p.0.05)
(fig 3A). The increase in the relative level of Egr-1 mRNA in
the 30/60 minute IR jejunum over the sham jejunum reached
statistical significance (p,0.01). Levels of Egr-1 protein and
protein products of Egr-1 downstream target genes in the IR
jejunum were analysed by western blotting (fig 3B). A
marked increase in Egr-1, RANTES, and MCP-1 was detected
only in the 45/60 minute IR jejunum, and a slight increase in
expression of ICAM-1 was also detected in the 45/60 minute
IR jejunum. Immunohistochemistry showed expression of
ICAM-1 at endothelial cells of the blood capillaries in the
45/60 minute IR jejunum (fig 3C).
Subcellular distribution of Egr-1 in resident
macrophages of IR jejunum
Transcription factor Egr-1 is translocated into the nucleus to
induce expression of its target genes. Subcellular distribution
of Egr-1 in the sham and IR jejunum was investigated by
immunohistochemistry (fig 4). In the sham operation group,
only a few cells at the mucosal epithelium were stained for
Egr-1 (fig 4A). In the 30/60 minute IR jejunum, clear Egr-1
immunopositive cells were detected inside the villi, and Egr-1
protein was mainly localised in the cytoplasm (fig 4B). A
larger number of more intensely stained Egr-1 immuno-
positive cells were localised in the villi of the 45/60 minute IR
jejunum, and Egr-1 protein was found mainly in the nucleus
(fig 4C). Colocalisation studies revealed in 45/60 minute IR
injury section that ED2 immunopositive macrophages were
immunoreactive for Egr-1 (fig 4D). Western blotting of the
nuclear and cytoplasmic fractions of IR jejunum also revealed
the presence of nuclear Egr-1 in the 45/60 minute IR group
(fig 4E).
Effect of resident macrophage depletion on IR injury
To determine if Cl2MBP is effective in the depletion of
resident macrophages in the gut, Cl2MBP liposome and
control liposome injected rats were sacrificed three days post-
injection, and their gastrointestinal tracts processed for
immunohistochemistry to localise the resident macrophages
(ED2 immunopositive) and total macrophages (ED1 immu-
nopositive) in the liver and gut. Resident macrophages were
markedly decreased both in the liver and gut of Cl2MBP
liposome treated rats (fig 5A–D). The percentage of resident
macrophages to total macrophages decreased from 41.3%
(4.9) in control liposome treated guts to 1.8% (0.8) in the
Cl2MBP liposome treatment group (fig 5). Levels of expres-
sion of Egr-1, cytokines, and adhesion molecule ICAM-1 were
analysed in the jejunum of control and Cl2MBP liposome
Figure 3 Upregulation of early growth response factor 1 (Egr-1), RANTES, monocyte chemoattractant protein 1 (MCP-1), and intercellular adhesion
molecule 1 (ICAM-1) in ischaemia reperfusion (IR) gut. Reverse transcription-polymerase chain reaction (RT-PCR) was performed to analyse the relative
expression of Egr-1 in the IR (IR) and sham operation (sham) gut of the 30/60 minute (309/609) IR and 45/60 minute (459/609) IR groups (A). Weak
expression of Egr-1 mRNA was detected in control jejunum (control) and sham operation jejunum. A marked increase in Egr-1 mRNA expression in the
30/60 minute IR jejunum and a moderate increase in Egr-1 mRNA expression in the 45/60 minute IR jejunum were detected. Relative expression of
Egr-1 to b-actin was determined in each group and is shown next to the gel picture of RT-PCR. *Significant difference between the IR and sham jejunum.
Protein levels of Egr-1, RANTES, ICAM-1, and MCP-1 in the jejunum of different IR groups were analysed by western blotting (B). Actin was used as a
loading control for each lane. Elevated levels of Egr-1, RANTES, and MCP-1 were detected in the 45/60 minute IR jejunum. Immunoreactivity of
ICAM-1 was detected in villi (C), but only expressed in the 45/60 minute IR jejunum in endothelial cells (arrows) of blood capillaries.
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treatment groups. mRNA and protein levels of Egr-1 were
reduced in the Cl2MBP liposome treatment group (fig 5E, F).
Levels of RANTES and MCP-1 were reduced after Cl2MPB
treatment (fig 5F). In contrast, only a slight reduction in
ICAM-1 level was observed in the Cl2MBP liposome treat-
ment group (fig 5F). To examine if the depletion of gut
resident macrophages can alleviate mucosal damage after IR,
we performed histological analysis of the 45/60 minute IR
jejunum of Cl2MBP liposome and control liposome treated
rats. Sloughing of mucosal epithelium and villi destruction
were detected in the control jejunum (fig 6A). In contrast, the
mucosa appeared intact and epithelial sloughing was rarely
observed in the Cl2MBP liposome treated jejunum (fig 6B).
The percentage of damaged villi to total villi was reduced
from 34.2% (2.5) in the control liposome treated jejunum to
5.2% (2.2) in the Cl2MBP liposome treated jejunum.
DISCUSSION
In this study, we have reported that mucosal damage occurs
before PMN infiltration in an IR injured gut in a rat model. IR
induced mucosal damage was correlated with activation of
gut resident macrophages and upregulation of MPO and
Egr-1 of resident macrophages. Depletion of gut resident
macrophages by Cl2MBP significantly reduced mucosal
damage. The present study provides evidence suggesting that
activated resident macrophages play a key role in early IR
damage to the gut.
Sloughing of mucosal epithelium and ulceration of villi
have been recognised as early histological landmarks of IR
gut injury,2 and these were observed in 45/60 minute IR gut
in our model. However, only a few PMN were found at the
damaged villi and at the base of the crypt although clear
mucosal damage was evident at the IR jejunum. PMN were
localised at the base of the crypt in the 60/60 minute IR gut.
Massive PMN infiltration was detectable in the damaged area
after three hours of reperfusion. This finding is in line with
previous reports that PMN infiltration is detectable in
damaged tissues 4–6 hours after IR.31–33 Taken together, these
findings suggest that early mucosa damage in IR injury is not
attributable to PMN. Interaction between ICAM-1 on
endothelial cells and LFA-1 on PMN is a prerequisite for
PMN infiltration.34 ICAM-1 expression of endothelial cells
was first observed at 45/60 minute IR gut, which suggested
that IR induced mucosal damage began prior to PMN
Figure 4 Resident macrophages expressed a high level of early growth response factor 1 (Egr-1) in the ischaemia reperfusion (IR) jejunum. In the
sham operation jejunum, Egr-1 immunoreactivity was not detected in villi and only a few cells at the mucosal epithelium showed Egr-1 expression (A).
A few Egr-1 immunopositive cells (arrows) were localised in the villi of the 30/60 minute (309/609) IR jejunum (B), and the Egr-1 protein was in the
cytoplasm (inset). A large number of Egr-1 immunopositive cells (arrows) were localised in the damaged villi of the 45/60 minute (459/609) IR jejunum
(C), and the Egr-1 protein was mainly in the nuclei (inset). Cells showing cytoplasmic Egr-1 staining (Cytoplasmic +) and cells showing nuclear Egr-1
staining (Nuclear +) in villi of different treatment groups were counted and tabulated as shown. An immunofluorescent colocalisation study using anti-
Egr-1 antibody and ED2 antibody (D) in 45/60 minute IR injury gut indicated that ED2 immunopositive resident macrophages were also immuno-
positive for Egr-1 (arrowheads). Distribution of Egr-1 protein in the nuclear and cytoplasmic fractions of jejunum of 30/60 minute and 45/60 minute
IR groups were investigated with western blotting. Egr-1 was detected in the nuclear fraction (Egr-1n) of 45/60 minute IR jejunum while Egr-1 was
detected in cytoplasmic fractions (Egr-1c) in both groups (E). Actin was used as a loading control for each lane.
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infiltration, and corroborates a report that anti-PMN anti-
serum fails to prevent tissue damage after IR in rats.33 Our
results also suggest the importance of ischaemia in the
priming of gut damage in which longer ischaemia results in
more damage after reperfusion.
Elevated tissue MPO enzyme activity has been frequently
used as an indication of PMN infiltration in IR injuries.18
However, monocytes and macrophages also express MPO,
which indicates that elevated tissue MPO activity is not
necessarily derived from infiltrated PMN. Furthermore, IR
induced mucosal damage began prior to PMN infiltration,
which indicated that elevated MPO activity in the early phase
of IR gut injury was not attributed to PMNs. Immunostaining
using an anti-MPO antibody and tissue macrophage marker
(ED2) revealed that resident macrophages in IR guts
expressed MPO enzyme. Activated macrophages in vitro14
have already been shown to express a high level of MPO
activity. Indeed, resident macrophages in the IR jejunum
expressed activated macrophage markers LFA-135 and iNOS,36
suggesting that resident macrophages were activated in the
IR gut. Elevated expression of MPO in resident macrophages
and increased tissue MPO levels were detected in the
30/60 minute IR jejunum, and mucosal damage was evident
in the 45/60 minute IR jejunum. MPO catalyses the produc-
tion of OCl2 and chloramines which have already been
demonstrated to cause gastric mucosal cell apoptosis and cell
sloughing.16 17 Elevated MPO activity is associated with
pulmonary injury, renal glomerular damage, and the initia-
tion of atherosclerotic lesions.37 We failed to detect mucosal
damage in the jejunum after prolonged ischaemia (two
hours; unpublished data). This suggests that the oxygen
burst during reperfusion triggers the cascade of cellular
activations and molecular events leading to IR damage.
To prove that resident macrophages were involved in
gut IR injury, we compared IR damage in Cl2MBP liposome
and control liposome treated rats. Cl2MBP liposome can
Figure 5 Intraperitoneal injection of dichloromethylene bisphosphonate (Cl2MBP) depleted resident macrophages from the gut and liver. Sections
from the liver (A, C) and jejunum (B, D) of rats treated with control liposome or Cl2MBP liposome were immunostained with ED2 antibody to localise
resident macrophages. ED2 immunopositive resident macrophages (arrows) were localised in the liver (A) and jejunum (B) of control liposome treated
rats but were undetectable in the liver (C) and jejunum (D) of Cl2MBP liposome treated rats. The percentage of ED2 immunopositive resident
macrophages versus ED1 immunopositive total macrophages in the control liposome treated and Cl2MBP liposome treated jejunum was determined
and tabulated as shown (number of views studied for reach group=30). Expression of early growth response factor 1 (Egr-1) mRNA in the control
liposome treatment group and the Cl2MBP treatment group was analysed by reverse transcription-polymerase chain reaction (E). Levels of Egr-1,
cytokines, and intercellular adhesion molecule 1 (ICAM-1) in the jejunum of the control liposome treatment group and the Cl2MBP treatment group were
analysed by western blotting (F). Reduction of Egr-1, RANTES, and monocyte chemoattractant protein 1 (MCP-1) was observed in the Cl2MBP treatment
group. In contrast, only a slight reduction in the level of ICAM-1 was observed in the Cl2MBP treatment group compared with that in the control
liposome treatment group.
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specifically deplete resident macrophages in the gut without
changing PMN activity.38 39 The percentage of resident
macrophages (ED2 immunopositive) to total macrophages
(ED1 immunopositive) in the gut decreased from 41.3% in
control liposome treated guts to only 1.8% in the Cl2MBP
liposome treated gut. Only ED2 immunopositive resident
macrophages were depleted in Cl2MBP treated rats indicating
that Cl2MBP was specific in the depletion of resident
macrophages. The degree of IR induced mucosal damage
and villi destruction was markedly reduced in the Cl2MBP
liposome treated jejunum compared with the control
jejunum. Mucosal damage was not detectable in resident
macrophages depleted rats even after three hours of reperfu-
sion, and very few PMN were localised at the villi. Our
findings on IR injury to resident macrophage depleted guts
suggest that resident macrophages contribute to the initia-
tion of mucosal damage in IR.
Colocalisation analysis established that resident macro-
phages in the damaged area expressed Egr-1. Activation of
resident macrophages induces mRNA and protein expression
of Egr-1 gene, and nuclear compartmentalisation of Egr-1
protein in resident macrophages. Involvement of Egr-1 in
lung IR injury has been shown in mice. PMN infiltration and
upregulation of cytokines, including RANTES and MCP-1, in
mouse lungs after IR challenge are markedly reduced in Egr-1
knockout mice and these mice show very mild IR damage in
lung tissue.22 The reduction in Egr-1, RANTES, and MCP-1
after Cl2MBP treatment indicated that macrophages pro-
duced these cytokines. However, studies of gut IR in Egr-1
knockout mice could further clarify the Egr-1 function in the
onset of gut IR damage. Our data suggest the PMN
infiltration by Egr-1 upregulation is not directly implicated
in the onset of gut IR injury. Reduction of PMN infiltration in
Cl2MBP treated guts after IR is likely to be an indirect effect
of reduced macrophage derived cytokines that induce PMN
infiltration.40
In summary, activated resident macrophages in IR gut
express a high level of MPO, Egr-1, and proinflammatory
cytokines. Elevated MPO activity catalyses the production of
reactive free radicals during reperfusion, causing initial
mucosal epithelial cell death. Accumulation of proinflamma-
tory cytokines induces PMN infiltration, resulting in further
tissue damage. Further exploration of potential therapeutic
intervention for IR damage might therefore profitably be
directed towards resident macrophages, as they have the
capacity to prevent initial mucosal destruction and arrest
subsequent tissue damage.
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Answer
From question on page 1771
Terminal ileoscopy revealed multiple red spots and raised cherry red bumps 3–5 mm in
diameter, with a mosaic pattern of the mucosa around their base. Biopsies revealed oedema
in the mucosa and arteriolar dilations that sometimes contained fibrin thrombi and were
compatible with hypertensive portal ileopathy. Videocapsule endoscopy revealed diffuse
involvement of the small intestine, with increasingly severe vascular lesions from the
proximal jejunum up to the distal ileum where these particular raised red bumps were
exclusively located. All of the lesions were attributed to portal hypertension enteropathy and
considered to be the cause of the recurrent gastrointestinal bleeding. The patient was given
80 mg/day propranolol and six months later he no longer exhibited either melena or a
relapsing decrease in haemoglobin.
This case exhibited a novel endoscopic appearance of portal hypertensive enteropathy
characterised by raised red bumps in the ileum, combined with particular histological
features similar to those of gastric antral vascular ectasia.
doi: 10.1136/gut.2003.034611
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